Virological and Immunological Aspects of AIDS Pathogenesis

by Brian Conway, Francisco J Diaz-Mitoma
Published 1994-01-01

Repeated spontaneous clearance of hepatitis C virus infection in the setting of long-term non-progression of HIV infection

by Genevieve Kerkerian, Arshia Alimohammadi, Tyler Raycraft, Brian Conway
Published 2017-10-01

Heterosexual Transmission of Human Immunodeficiency Virus Infection – Strategies for Prevention

by Brian Conway, D William Cameron, Francis A Plummer, Allan R Ronald
Published 1991-01-01

Factors Associated with Spontaneous Clearance of Hepatitis C Virus among Illicit Drug Users

by Jason Grebely, Jesse D Raffa, Calvin Lai, Mel Krajden, Brian Conway, Mark W Tyndall
Published 2007-01-01

Nelfinavir and Non-Nucleoside Reverse Transcriptase Inhibitor-Based Salvage Regimes in Heavily Hiv Pretreated Patients

by Jean-Guy Baril, Eric A Lefebvre, Richard G Lalonde, Stephen D Shafran, Brian Conway
Published 2003-01-01

A Hepatitis C Educational Needs Assessment of Canadian Healthcare Providers

by Reza Naghdi, Karen Seto, Carolyn Klassen, Didi Emokpare, Brian Conway, Melissa Kelley, Eric Yoshida, Hemant A. Shah
Published 2017-01-01

Directly Observed Therapy with Azithromycin for Skin and Soft Tissue Infections in Injection Drug Users

by Harout K Tossonian, Brian Conway, Jesse D Raffa, Mark Viljoen, Milan Khara, Annabel Mead, Heather Culbert, Stanley DeVlaming
Published 2007-01-01

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment

by Mark Hull, Stephen Shafran, Alex Wong, Alice Tseng, Pierre Giguère, Lisa Barrett, Shariq Haider, Brian Conway, Marina Klein, Curtis Cooper
Published 2016-01-01

Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging.

by Makan Golizeh, Carlos E Melendez-Pena, Brian J Ward, Sahar Saeed, Cynthia Santamaria, Brian Conway, Curtis Cooper, Marina B Klein, Momar Ndao, Canadian Co-Infection Cohort (CTN222)
Published 2018-01-01

Understanding Variable Motor Responses to Direct Electrical Stimulation of the Human Motor Cortex During Brain Surgery

by Daniel M. Aaronson, Eduardo Martinez Del Campo, Timothy F. Boerger, Brian Conway, Sarah Cornell, Matthew Tate, Wade M. Mueller, Edward F. Chang, Max O. Krucoff, Max O. Krucoff
Published 2021-10-01

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

by Curtis L. Cooper, Daniel Read, Marie-Louise Vachon, Brian Conway, Alexander Wong, Alnoor Ramji, Sergio Borgia, Ed Tam, Lisa Barrett, Dan Smyth, Jordan J. Feld, Sam Lee, on behalf of the CANUHC Cohort
Published 2020-09-01

Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults.

by Curtis Cooper, Anona Thorne, Marina Klein, Brian Conway, Guy Boivin, David Haase, Stephen Shafran, Wendy Zubyk, Joel Singer, Scott Halperin, Sharon Walmsley, CIHR Canadian HIV Trials Network Influenza Vaccine Research Group
Published 2011-03-01

A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection.

by Joseph B Margolick, Linda Apuzzo, Joel Singer, Hubert Wong, Terry Lee, Joel E Gallant, Phillippe El-Helou, Mona R Loutfy, Anita Rachlis, Christopher Fraser, Kenneth Kasper, Cécile Tremblay, Harout Tossonian, Brian Conway
Published 2015-01-01

Micronutrient deficiency and treatment adherence in a randomized controlled trial of micronutrient supplementation in ART-naïve persons with HIV.

by Louise Balfour, Johanna N Spaans, Dean Fergusson, Harold Huff, Edward J Mills, Charles J la Porte, Sharon Walmsley, Neera Singhal, Ron Rosenes, Nancy Tremblay, M John Gill, Hugues Loemba, Brian Conway, Anita Rachlis, Edward Ralph, Mona Loutfy, Ranjeeta Mallick, Rika Moorhouse, D William Cameron
Published 2014-01-01

The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol

by Madeleine Durand, Carl Chartrand-Lefebvre, Jean-Guy Baril, Sylvie Trottier, Benoit Trottier, Marianne Harris, Sharon Walmsley, Brian Conway, Alexander Wong, Jean-Pierre Routy, Colin Kovacs, Paul A. MacPherson, Kenneth Marc Monteith, Samer Mansour, George Thanassoulis, Michal Abrahamowicz, Zhitong Zhu, Christos Tsoukas, Petronela Ancuta, Nicole Bernard, Cécile L. Tremblay, For the investigators of the Canadian HIV and Aging Cohort Study
Published 2017-09-01

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

by Evan B. Cunningham, Behzad Hajarizadeh, Olav Dalgard, Janaki Amin, Margaret Hellard, Graham R Foster, Philip Bruggmann, Brian Conway, Markus Backmund, Geert Robaeys, Tracy Swan, Philippa S. Marks, Sophie Quiene, Tanya L Applegate, Martin Weltman, David Shaw, Adrian Dunlop, Julie Bruneau, Håvard Midgard, Stefan Bourgeois, Maria Christine Thurnheer, Gregory J Dore, Jason Grebely, on behalf of the ACTIVATE Study Group
Published 2017-06-01